Skip to main content
ASRT
NASDAQ Life Sciences

Assertio 同意被 Garda Therapeutics 收购

feedReported by Dow Jones Newswires
Sentiment info
Neutral
Importance info
9
Price
$18.41
Mkt Cap
$118.655M
52W Low
$7.706
52W High
$20.45
Market data snapshot near publication time

summarizeSummary

Assertio Holdings, Inc. 已宣布同意被 Garda Therapeutics 收购。这是 Assertio 的一个非常重要的事件，因为收购从根本上改变了公司的未来和投资论点。虽然标题没有提供具体的财务条款或溢价，但最终协议表明了一项重大公司交易。这则新闻可能会引发大量交易活动和对 ASRT 股票价格的重新评估。交易者将密切关注交易的全部条款，包括收购价格和预计关闭时间表。

在该公告发布时，ASRT的交易价格为$18.41，交易所为NASDAQ，所属行业为Life Sciences，市值约为$1.2亿。 52周交易区间为$7.71至$20.45。 这则新闻被评估为中性市场情绪，重要性评分为9/10。 来源：Dow Jones Newswires。

show_chartPrice Chart

Share this article

Copied!

feed ASRT - Latest Insights

ASRT
Apr 21, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Announces April 29 Tender Offer Commencement for Garda Therapeutics Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 14, 2026, 4:41 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Completes $35M Product Divestiture to Cosette Pharma, Bolstering Cash Ahead of Acquisition
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 09, 2026, 8:09 AM EDT
Filing Type: SC TO-C
Importance Score:
9
Assertio Holdings Files Tender Offer Communication for $18/Share Cash Acquisition by Garda Therapeutics, Plus CVR
Sentiment: Positive
View Wiseek Article
ASRT
Apr 09, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
10
Assertio to be Acquired by Garda Therapeutics for $18/Share Cash Plus CVR; Divests Non-Rolvedon Assets to Cosette for $35M Upfront
Sentiment: Positive
View Wiseek Article
ASRT
Apr 08, 2026, 5:10 PM EDT
Source: Reuters
Importance Score:
8
Assertio Divests Sympazan® and Other Products to Cosette Pharma
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 08, 2026, 4:04 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
Assertio Agrees to Be Acquired by Garda Therapeutics
Sentiment: Neutral
View Wiseek Article
ASRT
Apr 06, 2026, 5:26 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Shareholders to Vote on 6.2% Equity Plan Increase and Director Elections
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 16, 2026, 5:07 PM EDT
Filing Type: 10-K
Importance Score:
8
Assertio Holdings Reports Increased Net Loss, Negative Cash Flow, and Details Reverse Stock Split
Sentiment: Negative
View Wiseek Article
ASRT
Mar 16, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
8
Assertio Holdings Reports Q4 Loss, Projects Significant FY2026 Adjusted EBITDA Growth
Sentiment: Neutral
View Wiseek Article
ASRT
Mar 13, 2026, 4:11 PM EDT
Source: Reuters
Importance Score:
7
Significant Loss of $2.71/Share, 48.3% Revenue Drop Expected for Assertio Holdings
Sentiment: Negative
View Wiseek Article